Immunization can be used as a booster dose for population aged 50 years and over
O UK gained a boost against Covid-19 this Monday, 15th. The Medicines and Health Regulatory Agency approved the vaccine designed by Modern to the omicron variant. The country is organizing an autumn “strategy” against the disease and, it is very likely, that the immunizing agent will be provided to the population aged 50 and over in the booster dose. Side effects are “mild and self-resolving,” according to Moderna chief executive Stephane Bancel. Approximately 70% of the most recent Covid-19 virus samples collected arise from the omicron subvariant BA.5. The trend is that the United States follow Britain’s decision. At Germanythe new vaccine should be released in September, according to the health minister.